Sunlight Active Drug Ingredients Private Limited

Sunlight Active Drug Ingredients Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24233TG2014PTC096658 Incorporated 03 December 2014 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2025
₹69.28 Cr
▼ 2% YoY
Net profit · FY 2025
₹1.49 Cr
Net margin 2.2%
EBITDA · FY 2025
₹4.56 Cr
EBITDA margin 6.6%
Authorised capital
₹4 Cr
Registered with MCA
Paid-up capital
₹3.58 Cr
Issued & subscribed
Open charges
₹50.28 Cr
Satisfied ₹90 Lakh
Company age
12 yrs
Est. 2014
Employees · EPFO
8
Provident fund records

About Sunlight Active Drug Ingredients Private Limited

Data last updated:

Sunlight Active Drug Ingredients Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 03 December 2014 and has been in existence for over 12 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24233TG2014PTC096658. Its GSTIN is 36AAVCS1693P1Z8 (Telangana). The company holds 3 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹3.58 Cr. It is led by directors Venkateswara Rao Talupula (Managing Director) and Sravya Talupula.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.

As per the financials filed for FY 2025, the company reported a revenue of ₹69.28 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹1.49 Cr (net margin 2.2%) and EBITDA of ₹4.56 Cr (EBITDA margin 6.6%). Revenue has grown at a compounded annual rate (CAGR) of 30% over three years and 22% over five years.

The company has about 8 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹50.28 Cr and satisfied charges of ₹90 Lakh on record. Court records list 3 cases involving the company, including 3 filed by the company; 2 cases are pending. The company has 4 deals on record (2 rights issues, 2 funding rounds), with disclosed funding of ₹2.16 Cr; the latest was in December 2020. Its 9 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 5 smaller; the largest is Chemcrux Enterprises Limited with revenue of ₹71.5 Cr.

Sunlight Active Drug Ingredients Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-25-0001372). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sunlight-adi.com.

Company details

CIN U24233TG2014PTC096658
Registration Number 096658
Incorporation Date 03 December 2014
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-25-0001372
Key People
Venkateswara Rao Talupula Managing Director Sravya Talupula Director

Recognitions & Rankings of Sunlight Active Drug Ingredients

MSME (Udyam registered) Ministry of MSME
Category
Small (2023-24)
Udyam number
UDYAM-TS-25-0001372

Contact details

Sunlight Active Drug Ingredients Private Limited's registered office is in Hyderabad, Telangana. Its website is sunlight-adi.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    sunlight-adi.com
  • Registered Address
    Plot No.64 4th Floor Sy No.342 Road No.5 Aleap Industrial Estate Gajularamaram Q, Utbullapur, Hyderabad, Telangana, India – 500090
  • Industry
    Pharma, API Manufacturers

To see the full contact details of Sunlight Active Drug Ingredients Private Limited, buy the company report.

Comprehensive company report
Sunlight Active Drug Ingredients Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Sunlight Active Drug Ingredients is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Sunlight Active Drug Ingredients Private Limited, buy the company report.

Financials of Sunlight Active Drug Ingredients Private Limited

FY 2024 filings available

Sunlight Active Drug Ingredients Private Limited reported revenue of ₹69.28 Cr (down 2% YoY) for FY 2025.

Revenue · FY 2025
₹69.28 Cr ▼ 2%
Net profit · FY 2025
₹1.49 Cr margin 2.2%
EBITDA · FY 2025
₹4.56 Cr margin 6.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 2%
3 years · compounded
▲ 30%
5 years · compounded
▲ 22%
EBITDA CAGR growth
1 year
▼ 3%
3 years · compounded
▲ 14%
5 years · compounded
▲ 20%

Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 22%. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹4.56 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.49 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin6.6%
Net Profit Margin2.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Sunlight Active Drug Ingredients Private Limited, buy the company report.

Board of directors of Sunlight Active Drug Ingredients Private Limited

Sunlight Active Drug Ingredients has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Venkateswara Rao Talupula
Also directs: Organo Metallics Private Limited, Guardinor Api Private Limited
Managing Director03 Dec 201411 Years 11 MonthsCurrent
Sravya Talupula
Also directs: Guardinor Api Private Limited
Director24 Jul 201511 Years 3 MonthsCurrent
View all directors

Peer comparison

Sunlight Active Drug Ingredients Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Chemcrux Enterprises Limited₹71.5 Cr (FY 2025)-10.0%Vadodara, Gujarat, India
Nico Orgo Marketing Private Limited₹70.53 Cr (FY 2024)-50.0%Kheda, Gujarat, India
Actis Generics Private Limited₹70.08 Cr (FY 2024)7.0%Vijayawada, Andhra Pradesh, India
Vibrant Pharmachem Private Limited₹69.73 Cr (FY 2024)-10.0%Raichur, Karnataka, India
Sunlight Active Drug Ingredients Private Limitedthis company₹69.28 Cr (FY 2025)₹1.49 Cr2.2%-2.0%8Hyderabad, Telangana, India
Amgis Lifescience Limited₹68.51 Cr (FY 2024)13.0%Vapi, Gujarat, India
Sanmar Speciality Chemicals Limited₹68.48 Cr (FY 2018)11.0%Chennai, Tamil Nadu, India
Lohitha Life Sciences Private Limited₹67.8 Cr (FY 2024)7.0%Hyderabad, Telangana, India
Beloorbayir Biotech Limited₹67.42 Cr (FY 2021)-4.0%Bangalore, Karnataka, India
Satyadivis Pharmaceuticals Private Limited₹67.35 Cr (FY 2024)2.0%Jinnaram, Telangana, India

To see the full peer comparison of Sunlight Active Drug Ingredients Private Limited, buy the company report.

Auditor

Sunlight Active Drug Ingredients Private Limited is audited by M S R & ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
M S R & ASSOCIATESFY 2023014318S

Shareholding

The shareholding of Sunlight Active Drug Ingredients Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Sunlight Active Drug Ingredients Private Limited, buy the company report.

Charges & borrowings

Open charges
₹50.28 Cr
Satisfied charges
₹90 Lakh
Breakdown by lending institutions
Others₹49.71 Cr
Hdfc Bank Limited₹0.57 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
29 Nov 2025101201358Others₹2 CrOpen
24 Jul 2025101130829Others₹2 CrOpen
27 Mar 2025101077958Others₹10 CrOpen
18 Apr 2023100711230Hdfc Bank Limited₹56.9 LakhOpen
06 Nov 2021100525558Others₹23.52 CrOpen

To see the full charge records of Sunlight Active Drug Ingredients Private Limited, buy the company report.

Total charge records: 9 View all charges

Deals & funding

Sunlight Active Drug Ingredients Private Limited has 4 deals on record (2 rights issues, 2 funding rounds), with disclosed funding of ₹2.16 Cr; the latest was in December 2020.

Total deals
4
Rights issues
2
Funding rounds
2
Disclosed funding
₹2.16 Cr

Deals on record (4 of 4)

WhenDealAmountParties
Dec 2020Rights issue₹1.26 CrInvestors: 3 individuals
Jun 2018Rights issue₹81.2 LakhInvestors: T Venkateswara Rao HUF, an individual
Jun 2018Funding round₹22.7 LakhInvestors: an individual
Jan 2016Funding round₹1.94 CrInvestors: 3 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Sunlight Active Drug Ingredients Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Sunlight Active Drug Ingredients Private Limited has a workforce of 8 employees on its EPFO records as of Mar 29, 2024, across 1 active EPFO establishment.

Employee count
8
Active EPFO establishments
1
Employee growth
-46.67%

GST

Sunlight Active Drug Ingredients has 3 GST registrations: 1 active and 2 cancelled or inactive.

Total GSTINs
3
Active
1
Cancelled / inactive
2
GSTINStateStatusRegistered on
36AAVCS1693P1Z8TelanganaActive01 Jul 2017

To see the full GST registrations and return filing status of Sunlight Active Drug Ingredients Private Limited, buy the company report.

Recent activity

Sunlight Active Drug Ingredients Private Limited has 6 board changes on record since 2014: 2 appointments and 4 cessations. The latest: Nithya Talupula ceased to be Director on 28 Jan 2023.

Charges
A charge with Others amounted to Rs. 2.00 Cr with Charge ID 101201358 was registered on 29 Nov 2025.
Charges
A charge with Others amounted to Rs. 2.00 Cr with Charge ID 101130829 was registered on 24 Jul 2025.
Charges
A charge with Others amounted to Rs. 10.00 Cr with Charge ID 101077958 was registered on 27 Mar 2025.
AGM
Sunlight Active Drug Ingredients Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Sunlight Active Drug Ingredients Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.57 Cr with Charge ID 100711230 was registered on 18 Apr 2023.
Ceased
Nithya Talupula ceased to be Director.
Charges
A charge with Others of Rs. 23.52 Cr registered on 06 Nov 2021 with Charge ID 100525558 was modified on 21 Jan 2023.
Ceased
Kamella Sita Vijay Krishna ceased to be Additional Director.
Charges
A charge with Others amounted to Rs. 23.52 Cr with Charge ID 100525558 was registered on 06 Nov 2021.
Charges
A charge with Others amounted to Rs. 0.60 Cr with Charge ID 100492300 was registered on 29 Sep 2021.
Charges
A charge with Others of Rs. 11.41 Cr registered on 20 Aug 2018 with Charge ID 100204482 was modified on 13 Sep 2021.

9 earlier events are in the company report.

Frequently asked questions

Sunlight Active Drug Ingredients is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 03 December 2014 (12+ years old) and is registered under CIN U24233TG2014PTC096658.

Sunlight Active Drug Ingredients has 2 current directors:

The latest financial statements of Sunlight Active Drug Ingredients on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Sunlight Active Drug Ingredients is 36AAVCS1693P1Z8, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.

The CIN (Corporate Identification Number) of Sunlight Active Drug Ingredients is U24233TG2014PTC096658. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Sunlight Active Drug Ingredients has 3 court cases on record: 3 filed by the company. 2 are pending.

Sunlight Active Drug Ingredients was incorporated on 03 December 2014, making it 12+ years old. It is registered with the Registrar of Companies, Hyderabad.

Sunlight Active Drug Ingredients has 4 deals on record (2 rights issues, 2 funding rounds), with disclosed funding of ₹2.16 Cr; the latest was in December 2020.

The peers of Sunlight Active Drug Ingredients by revenue are Chemcrux Enterprises Limited, Nico Orgo Marketing Private Limited, Actis Generics Private Limited, Vibrant Pharmachem Private Limited, Amgis Lifescience Limited and 4 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Nithya Talupula ceased to be Director on 28 Jan 2023. Kamella Sita Vijay Krishna ceased to be Additional Director on 30 Mar 2022. Sravya Talupula ceased to be Additional Director on 30 Sep 2015. Sunlight Active Drug Ingredients has 6 board changes on record in total.

Yes, Sunlight Active Drug Ingredients is registered as a small enterprise under Udyam registration (number: UDYAM-TS-25-0001372).